Memorandum 59
RESPONSES TO LETTER[71]
FROM THE COMMITTEE TO EXPERTS IN EMBRYO RESEARCH
Submission from Alison Murdoch, Institute
of Human Genetics, Newcastle University
I confirm that I was at the meeting on the 30
November 2006. I do not recall anyone at the meeting speaking
against the creation of hybrid or chimera embryos in vitro. On
the contrary, there was general agreement that work with animal
cells was essential if this are of science is to develop significantly.
This includes the in vitro use of combined animal and human proteins,
cells or tissue.
I do not support the government plans that you
have quoted. Their proposals are not logical. If it is considered
that at some time in the future the creation of hybrid embryos
is justified, I presume that this will be based on scientific
advice that it is an appropriate and needed development. Scientific
advice is that it is appropriate and needed now so why not address
the problem now?
I would also like to bring your attention to
another proposal in the White Paper. Section 2.15 relates to "artificial
gametes" and proposes a ban on their use for reproductive
purposes. Whilst we are not yet ready to consider them (sperm
or eggs) for clinical use, I do not believe that it is far away,
considering the very loose definition given of "non-naturally
occurring gametes". A ban in the primary legislation would
be unnecessary since there are already adequate regulatory powers
relating to new clinical treatments that protect both the patient
and any resulting child. A ban will simply give rise to challenge
in the near future and is therefore not sensible legislation.
February 2007
Submission from Professor David H Barlow,
University of Glasgow
Thank you for seeking my opinion on the question
of hybrid and chimera embryos and legislation.
I attended the HFEA embryo research meeting
in November as a Member of the HFEA Scientific and Clinical Advances
Group (SCAG) and as a recent ex-Member of the HFEA. In the past
I have held an HFEA embryo research licence and I was Editor-in-Chief
of the journal "Human Reproduction" from 2000 to 2006.
My comment is that I believe the balance in
the statement below is correct ... "the creation of hybrid
and chimera embryos in vitro, should not be allowed. However,
the Government also proposes that the law will contain a power
enabling regulations to set out circumstances in which the creation
of hybrid and chimera embryos in vitro may in future be allowed
under licence, for research purposes only".
I believe it is important that the general public
are reassured that the creation of hybrids or chimeras will be
not be freely possible. The suggestion that there will be specific
regulations which define the circumstances in which it will be
legal, in a research context, to seek to create a hybrid embryo
or chimera. There will be groups in society who will consider
hybrids and chimeras to be unacceptable in any circumstances.
I believe that there is scientific justification for the creation
of hybrids and chimeras in experimental settings and definitely
without the intention of pregnancy establishment being attempted.
I believe that the proposed wording retains
control with the HFEA or its successor body for the issuing of
research licenses where the proposed experiments can be justified
and I believe that this is appropriate.
February 2007
Submission from Professor Jose B. Cibelli,
Michigan State University
I agree with:
"the creation of hybrid and chimera embryos
in vitro, should not be allowed. However, the Government also
proposes that the law will contain a power enabling regulations
to set out circumstances in which the creation of hybrid and chimera
embryos in vitro may in future be allowed under licence, for research
purposes only".[72]
Supplementary submission from Professor
Jose B. Cibelli
This is in response to an inquiry by the House
of Commons regarding the scientific basis for performing experiments
with human/animal chimeras. For the purpose of this analysis,
chimeras are defined as the combination of human embryonic stem
cells (ESCs) with animal embryos and or human cells and non-human
oocytes.
Please notice that I am not an ethicist and
I do not endorse nor condemn these experiments. Merely I am trying
to address whether these experiments could have scientific value.
Three approaches come to mind:
1. The combination of human embryonic stem
cells with host animal embryo during preimplantation development
only. These experiments are likely to generate very little or
no useful information since the period of time this chimera will
develop into a late-stage blastocyst is quite short.
2. The combination of human embryonic stem
cells with host animal embryo during preimplantation development
to be later transferred into a recipient female. Scientists might
be compelled to transfer these embryos into the uterus of a surrogate
mothereg of the same species from which the host embryo
was takenin an attempt to obtain human differentiated cells
that can not be generated using any other approach. This is alternative
can be of great value and offer new insights regarding in vivo
cell differentiation processes in human. Scientists could genetically
engineer human ESCs that will only develop into a specific cell
type and therefore there should be no risk for those cells to
contribute to the central nervous system, if that is an issue
of concern.
3. The third approach relates to the use
of Inter-Species Somatic Cell Nuclear Transfer (SCNT). It is possible
to combine an enucleated non-human oocyte with a human somatic
cell and artificially trigger preimplantation development. There
is one report describing the production of human embryos by SCNT
using rabbit oocytes as hosts. If these experiments are independently
replicated, scientists will have at their disposal a powerful
tool to study human somatic cell dedifferentiation without having
to rely on human oocytes. There would be no scientific justificationat
least to meto attempt transferring these embryos into a
uterus. All the studies can be done in vitro.
In summary, I believe approach £2 and £
3 have scientific merit and deserve to be taken into consideration
when drafting new legislation.
February 2007
Submission from Professor Peter Braude, Kings
College London
"the creation of hybrid and chimera embryos
in vitro, should not be allowed. However, the Government also
proposes that the law will contain a power enabling regulations
to set out circumstances in which the creation of hybrid and chimera
embryos in vitro may in future be allowed under licence, for research
purposes only".
I see great scientific merit in being able to
examine the effects of nuclear cytoplasmic interaction following
insertion of a somatic nucleus into an oocyte to foster not only
understanding the processes of dedifferentiation and dedifferentiation
during early development of the mammalian (and especially human)
embryo, but also to extrapolate this to understandings of cell
control in cancer evolution, and the processes needed to generate
stem cells in vitro. Although I also support the limited use of
human altruistic or paid donors to supply human oocytes, as a
gynaecologist and specialist in reproductive medicine, I believe
that it would be fairer to women if use of animal oocytes for
were allowed, thus reducing the demand for human material in the
preliminary stages. I feel that significant progress can also
be made using suitable animal oocytes, cow being particularly
useful as material can be obtained from abattoir material and
would not require the use of laboratory animals. I cannot see
any immediate purpose for their use therapeutically and therefore
strongly support their use in research only. The degree of chimerism
in these cases would be small (bovine mtDNA and RNA) but the amount
that might be learned about the above processes, as well as mitochondrial
interaction could be enormous.
Accepting this, I am mystified by the wording
of the supplied paragraph. It seems to me that it should say "should
be allowed, but only under strict controls and regulations as
set out ....." allowing this work to take place immediately
if required and justified after peer review. As it stands I think
it is ambiguous, unnecessarily complex, and most certainly would
cause delay and likely legal challenges.
February 2007
Submission from Professor Alan Trounson,
Monash Institute of Reproduction and Development
I essentially agree and believe it is important
to establish regulations that allow chimeric embryos be formed
under special circumstances for research.
The recommendation is a double proposalban
human chimeric and hybrid embryosbut introduce regulations
that permits this activity under license for research purposes.
Like many others, I think that chimeric and
hybrid embryos represent a useful model for research and this
should be permitted under license. Unlicensed and unregulated
experiments will be a concern to the community and a licensing
process will ensure some degree of monitoring that will probably
relieve this tension.
The merits of research involving mixed cell
chimeras can be obvious in determining the normality of the human
cells in contributing to tissue systems. There may be no other
way to assess the possible preclinical usefulness and functional
normality of cells derived from embryonic stem cells for instance.
This could include the need to study early lineage cell types
such as germ cells which may need to be combined with embryos
of animal species to observe their capacity to develop into sex
cells (gameteseggs and sperm). It would be important that
any chimeric animal formed should not be bred but be subject to
scientific analysis. Similarly, other cell progenitors could be
studied in animal models of human diseasesthis is a common
experiment involving a wide spectrum of cell types and disease
models that are seeking evidence for repair of the disease and
eventual clinical assessment in human patients.
These experiments normally involve agreement
of animal ethics committees and there may be studies in the category
that are trivial and be dealt with by these committees but the
combination of cells in the early embryo that could result in
significant chimerism in the gonads and central nervous system
may be better covered by a licensing process.
The production of human-animal hybridsnormally
understood to be a combination of sperm and eggs of two different
species, can be a vexed issue. A degree of hybridization may be
recognized in nuclear transfer involving human cell nuclei inserted
into animal eggs. These interspecies manipulations may also be
concerning even though they are experimental and be aimed at addressing
the lack of human eggs available for disease specific stem cells.
The merit for having a model for disease that can be interrogated
in the laboratory could be very important. It seems appropriate
that this should also require a license and some degree of monitoring
to ensure community comfort.
February 2007
Submission from Professor Lorraine Young,
Wolfson Centre for Stem Cells, Tissue Engineering and Modelling
I completely support the current Government
proposal that:
"the creation of hybrid and chimera embryos
in vitro, should not be allowed. However, the Government also
proposes that the law will contain a power enabling regulations
to set out circumstances in which the creation of hybrid and chimera
embryos in vitro may in future be allowed under licence, for research
purposes only".
My research over the last few years has examined
how the DNA of eggs and sperm restructures after fertilisation
of the egg. My laboratory has shown that (1) some of the same
restructuring applies to somatic cells after SCNT and that (2)
considerable species differences exist in this process, especially
between the rabbit and human- two species being considered in
the production of chimaeric embryos for stem cell research.
The relevant references are below.
Nathalie Beaujean, Jane E.Taylor, Michelle McGarry,
Pasqualino Loi, Graznya Ptak, Cesare Galli, Giovanna Lazzari,
Donald MacLeod, Adrian Bird, Lorraine E. Young* and Richard R.
Meehan (2004). The effect of interspecific oocytes on demethylation
of sperm DNA. PNAS 101:7636-40.
Beaujean N, Hartshorne G, Cavilla J, Taylor
J, Gardner J, Wilmut I, Meehan R and Young L. (2004). Non-Conservation
of Mammalian Preimplantation Methylation Dynamics. Curr Biol 14(7):R266-7.
Nathalie Beaujean, Jane Taylor, John Gardner,
Ian Wilmut, Richard Meehan and Lorraine Young (2004) Effect of
Limited DNA Methylation Reprogramming in the Normal Sheep Embryo
on Somatic Cell Nuclear Transfer. Biology of Reproduction 71(1):185-93
Lorraine E. Young and Nathalie Beaujean. DNA
Methylation in the Preimplantation Embryo: The differing stories
of the mouse and sheep. Animal Reproduction Science 82-83; 61-78.
February 2007
Submission from Professor Richard Gardner,
University of Oxford
I hope a simple reply to the letter by email
is acceptable. I do not support the proposal of the Government
regarding chimaeras and hybrids, and am concerned that the term
"hybrid" in particular has led to misunderstanding regarding
the possible use of animal eggs deprived of their nuclear DNA
as a vehicle for research on human therapeutic cloning. Defined
biologically, an interspecific hybrid is the product of fertilization
of an egg of one species by the sperm of another. By earlier permitting
penetration of denuded hamster eggs by human sperm as a test of
the fertilizing potential of the latter, the initial stage of
development of hybrids has already been sanctioned in the past.
Further very short-term production of such hybrids is vital for
being able to check the chromosmal normality or otherwise of human
sperm in case of suspected male infertility. At present, I can
think of no compelling reason to extend the development of such
interspecific true hybrids beyond the fertilized egg stage.
Perhaps the best term for an embryo produced
by transplanting human somatic cell nuclei into enucleated animal
egg is a "cybrid". Given the dire shortage of human
eggs for research into at present inefficient procedures such
as therapeutic cloning, this strategy offers the only practical
way of carrying such research forward.
At present, chimaeras offer the only critical
way of determining whether embryonic stem cells are normal and
thus safe to use therapeutically, given that studies on animal
embryonic stem cells have revealed that having a normal set of
chromosomes is no guarantee of physiological normality.
Finally, according to the Human Fertilization
and Embryology Act (1990), a licence for research cannot authorise
any activity unless it appears to the Authority to be necessary
or desirable for a purpose specified in the relevant Regulations
of the Act. Moreover, granting of such a licence requires that
theAuthority is satisfied that any proposed use of embryos is
necessary for the purposes of the research.
These conditions would seem to provide sufficient
safeguard against inappropriate or premature use of such novel
techniques and procedures on human material to render the cumbersome
process of their interim prohibition through legislation unnecessary.
February 2007
Submission from Dr Daniel Brison, St Mary's
Hospital
Thank you for your letter of 22 February. I
do not agree with the current goverment position that creation
of hybrids (placing a human nucleus into an animal egg cell) should
not be allowed, rather I believe that it should be allowed. If
it is not allowed in the first instance, then it is essential
that the regulator should have the power to permit this research
without recourse to primary legislation. Allowing creation of
hybrids and or chimeras for research purposes only is appropriate
at this moment in time.
Although I am not a specialist in the area of
oocyte biology or nuclear:cytoplasmic interactions, the reason
that I believe this research should be permitted immediately is
that I believe that it has the potential to provide a number of
important benefits: increasing basic understanding of nuclear-cytoplasmic
interactions, increasing the understanding of nuclear reprogramming
by the oocyte, and advancing the technology of somatic cell nuclear
transfer cloning (SCNT). With respect to this last, I believe
that there is much benefit to be gained by using the hybrid system,
as this can be regarded as an intermediate step between basic
research using animal-only SCNT and human research using human
nuclei into human eggs. The former is valuable but limited in
that there are basic differences between animal and human oocytes
which limit the relevance of animal data to the human, the latter
is limited by the supply of human oocytes and ethical concerns
over asking women to donate oocytes for this purpose.
The public clearly have a concern over this
research, for two reasons: (1) there is concern that we show respect
for the human embryo and (2) there is concern over the prospect
of animal human hybrids being produced for reproduction. With
respect to (1) we have some precedent for this, in that it is
permitted to mix human nuclear material with egg cytoplasm containing
mitochondria from another individual and this is not regarded
as modifiying the genome of the embryo. By this logic, creating
a hybrid zygote containing animal mitochondria should not be regarded
as a hybrid at all, but rather an entirely human genome. With
respect to (2) we have a precedent as SCNT for humans is allowed
for research but not reproduction.
I believe that it is essential to point out
the value of hybrid research, in order to help allay public concerns.
February 2007
Submission from Maureen WoodUniversity
of Aberdeen
Thank you for contacting me and my apologies
for replying so close to the deadline.
I am not in favour of the proposed legislation.
I believe that the option to transfer human
somatic cell nuclei into animal eggs should be available to researchers,
under licence of course. This avenue should not be closed when
it offers the possibility of investigating cell reprogramming
using readily available animal eggs. Research using human eggs
will be necessary too but all options should be explored to minimise
the number of human eggs required.
February 2007
Submission from Dr Luca Gianaroli, Societá
Italiana Studi di Medicina della Riproduzione (S.I.S.Me.R)
My position is in favour, in principle, of the
UK government proposal.
Please let me know the follow up of the matter.
February 2007
71 Annex 1. Back
72
Review of the Human Fertilisation and Embryology Act Proposals
for revised legislation (including establishment of the Regulatory
Authority for Tissue and Embryos) December 2006 (Command Paper
6989). Para 2.85. Back
|